Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc is an American consumer healthcare company that develops, manufactures, markets, and distributes over-the-counter (OTC) healthcare products and household cleaning items. The company owns and manages a diverse portfolio of well-known consumer brands, including Clear Eyes, Monistat, Dramamine, Luden's, Chloraseptic, and BC Powders, distributed across North America and international markets. Its core business activities encompass OTC brand marketing, product formulation, supply chain management, and retail wholesale distribution. Revenue is derived primarily from the wholesale sale of healthcare products to mass merchandisers, drugstores, supermarkets, and e-commerce retailers. Prestige Consumer Healthcare holds a leading market position in niche over-the-counter healthcare brands in North America. The company is headquartered in Tarrytown, New York, United States, and its common stock trades on the New York Stock Exchange.
13 of the funds FundTelligence covers report a position in Prestige Consumer Healthcare.
- Legal name
- Prestige Consumer Healthcare Inc
- Sector
- Consumer Staples
- Country
- United States
- Funds holding it
- 13
Funds holding Prestige Consumer Healthcare
- Nordea Globale Stabile Aktier - Etisk tilvalg — Nordea Funds · 0.66 % (full portfolio disclosed, July 2026)
- Nordea Stabile Aktier — Nordea Funds · 0.52 % (full portfolio disclosed, July 2026)
- Nordea Globale Stabile Aktier — Nordea Funds · 0.52 % (full portfolio disclosed, July 2026)
- Nordea Global Stable Equity Fund - Unhedged — Nordea Funds · 0.51 % (full portfolio disclosed, July 2026)
- Nordea Global Stable Equity Fund — Nordea Funds · 0.51 % (full portfolio disclosed, July 2026)
- Nordea Stabile Aksjer Global — Nordea Funds · 0.51 % (full portfolio disclosed, July 2026)
- Mercer Global Small Cap Equity Fund — Mercer · 0.33 % (full portfolio disclosed, December 2025)
- Nordea BetaPlus Enhanced Global Sustainable Small Cap — Nordea Funds · 0.23 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 13 funds holding it.